The Lung Institute: A First-of-its-Kind COPD Treatment Center Offering Stem Cell Therapy

COPD treatment centerThe Lung Institute is a COPD treatment center that offers hope to adults with all types of chronic obstructive pulmonary disease. Through autologous stem cell treatment, our skilled physicians can help certain patients improve their breathing, reduce lung scarring and slow the progression of conditions like emphysema, chronic bronchitis and pulmonary fibrosis.

The Lung Institute is the world’s first and only stem cell center to focus exclusively on COPD and interstitial lung diseases. More than 80 percent of our patients experience life-enhancing results from stem cell treatment, an innovative therapy that uses a patient’s own stem cells – not potent drugs or invasive surgery – to promote healing in the lungs. While COPD is not reversible, stem cell treatment has the potential to significantly improve quality of life. The procedure is relatively painless and performed on an outpatient basis over the course of two days, so patients are able to return to their daily routines shortly after treatment.

Coping with the effects of COPD can be a daily struggle. At the Lung Institute, we understand this, which is why we strive to make our patients’ treatment experience as comfortable and pleasant as possible. Our COPD treatment center is bright and airy, our office staff is friendly and knowledgeable and our physicians are committed to helping patients breathe easier and make informed decisions about their pulmonary health.

Since 2013, the Lug Institute has helped more than 4,000 patients manage their COPD symptoms and get back to enjoying the things they love most about life — whether that’s taking morning walks, attending sporting events or simply spending quality time with loved ones. Consider contacting our COPD treatment center at (800) 729-3065 if you’re interested in learning more about how stem cell treatment may benefit you.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.